BIO-CAT Microbials, a leading microbial solutions company, will invest $35 million to expand its facility in Troy, Virginia. The project is expected to create 20 jobs.
The company will break ground on an initial 53,800 square-foot expansion phase in March of 2022, with potential future expansion up to an additional 100,000 square feet.
"This expansion will be a huge boon for our fermentation capabilities, allowing us to further scale our production to supply customers and partners, both old and new, with the best microbial products on the market," BIO-CAT CEO and Co-Founder Chris Schuler said. "The plans we have in place will make our Troy facilities truly best-in-class. We're looking forward to breaking ground and getting started."
BIO-CAT Microbials currently manufactures a dozen proprietary Bacillus microbial strains for the human probiotic, production and companion animal, and crop science markets. It sees this investment and corresponding state-of-the-art expansion as an opportunity to cement BIO-CAT Microbials as the premier source for breakthrough microbial solutions across a myriad of industries.
The company currently performs all fermentation in its Shakopee, Minnesota manufacturing site, but the expansion of the Troy, Virginia facility will provide BIO-CAT Microbials' customers with manufacturing redundancy that will further solidify supply chain reliability, which has become increasingly important in today's market.